Sector: Pharmaceuticals & Biotechnology
|Large Cap
J B Chemicals & Pharmaceuticals Ltd.
₹2,233.60
Invest in JBCHEPHARM with up to 2.86x margin.
Trade with MTF₹2200.00
₹2285.30
₹1603.50
₹2224.90
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 836.43 | 990.91 | 1,022.65 | 1,039.90 | 901.34 |
| Operating Expense | 641.50 | 721.41 | 724.29 | 746.78 | 670.36 |
| Operating Profit | 194.93 | 269.50 | 298.36 | 293.12 | 230.98 |
| Depreciation | 48.56 | 43.62 | 43.11 | 41.40 | 44.41 |
| Interest | 1.33 | 1.59 | 1.01 | 0.66 | 0.93 |
| Tax | 31.56 | 61.91 | 68.07 | 67.09 | 49.37 |
| Net Profit | 96.54 | 179.27 | 200.42 | 197.87 | 149.80 |
₹2233.60
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 53.7 | 47.8 | 47.7 | 47.6 | 47.6 | 48.8 |
| FII | 14.6 | 18.3 | 17.8 | 15.3 | 14.9 | 16.3 |
| DII | 16.4 | 18.7 | 19.6 | 22.8 | 23.3 | 21.4 |
| Public | 15.3 | 15.1 | 14.9 | 14.3 | 14.2 | 13.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.33 L | 2.04 L | 65.05% |
| Week | 2.25 L | 3.17 L | 70.95% |
| 1 Month | 2.1 L | 3.33 L | 63.06% |
| 6 Month | 1.72 L | 2.79 L | 61.71% |
Companies with no Debt
Benjamin Graham Value Screen
Expensive Stars (DVM)
Strong Momentum: Price above short, medium and long term moving averages
High Momentum Scores (Technical Scores greater than 50)
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 11 Feb, 2026 | 12.7 | INTERIM | 11 Feb, 2026 | Equity Share |
| 30 Jul, 2025 | 7 | FINAL | 30 Jul, 2025 | Equity Share |
| 07 Feb, 2025 | 8.5 | INTERIM | 08 Feb, 2025 | Equity Share |
| 14 Aug, 2024 | 6.75 | FINAL | 14 Aug, 2024 | Equity Share |
| 16 Feb, 2024 | 5.5 | INTERIM | 16 Feb, 2024 | Equity Share |
| 17 Aug, 2023 | 9.25 | FINAL | Equity Share | |
| 17 Feb, 2023 | 8.5 | INTERIM | 18 Feb, 2023 | Equity Share |
| 12 Aug, 2022 | 8 | FINAL | Equity Share | |
| 23 Feb, 2022 | 8.5 | INTERIM | 24 Feb, 2022 | Equity Share |
| 01 Sep, 2021 | 8 | FINAL | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹765.70 | ₹8,798 | ₹2,300 | ₹4,658.30 | ₹27,700 |
| % Change | -1.47% | 2.45% | -0.30% | -0.27% | -0.47% |
| Revenue TTM (₹ Cr) | ₹2,124.33 | ₹2,177.45 | ₹3,821.67 | ₹2,519.65 | ₹6,929.05 |
| Net Profit TTM (₹ Cr) | ₹591.79 | ₹200.89 | ₹1,035.98 | ₹722.43 | ₹1,552.02 |
| PE TTM | 74.10 | 107.10 | 38.40 | 29.70 | 37.60 |
| 1 Year Return | 36.93 | 7.87 | -16.8 | 4.91 | -10.56 |
| ROCE | 27.56 | - | 54.54 | 22.93 | - |
Torrent Pharmaceuticals Ltd.
₹ 4562.00
+1.69%
Lupin Ltd.
₹ 2291.00
+0.40%
Dr. Reddy's Laboratories Ltd.
₹ 1333.00
+1.97%
Cipla Ltd.
₹ 1414.60
+1.10%
Sai Life Science Ltd.
₹ 1175.20
+5.51%
OneSource Specialty Pharma Ltd.
₹ 1800.10
-1.88%
Emcure Pharmaceuticals Ltd.
₹ 1740.00
+1.54%
Mankind Pharma Ltd.
₹ 2457.50
-0.88%
Piramal Pharma Ltd.
₹ 179.26
+2.07%
Acutaas Chemicals Ltd.
₹ 2918.90
-1.09%
Gland Pharma Ltd.
₹ 2336.30
+0.10%
Laurus Labs Ltd.
₹ 1357.00
+1.00%
Alkem Laboratories Ltd.
₹ 5401.00
-0.06%
Biocon Ltd.
₹ 429.85
-0.09%
Divi's Laboratories Ltd.
₹ 6763.00
-1.80%
Ajanta Pharma Ltd.
₹ 3087.60
-0.64%
Zydus Lifesciences Ltd.
₹ 1074.20
+3.39%
Glenmark Pharmaceuticals Ltd.
₹ 2336.40
+3.42%
Wockhardt Ltd.
₹ 1636.80
+3.90%
Aurobindo Pharma Ltd.
₹ 1453.10
-0.71%
Natco Pharma Ltd.
₹ 1174.00
+0.37%
Sun Pharmaceutical Industries Ltd.
₹ 1840.70
-0.21%
Neuland Laboratories Ltd.
₹ 16740.00
+0.28%
Ipca Laboratories Ltd.
₹ 1571.30
-1.92%
By signing up I certify terms, conditions & privacy policy